[1] |
Auvin S, Cilio MR, Vezzani A, et al. Current understanding and neurobiology of epileptic encephalopathies[J]. Neurobiol Dis, 2016, 92(Pt A):72-89.
doi: 10.1016/j.nbd.2016.03.007
|
[2] |
Guo Z, Niu W, Bi Y, et a1. A study of single nucleotide polymorphisms of GRIN2B in schizophrenia from Chinese Han population[J]. Neurosci Lett, 2016, 630(6):132-135.
doi: 10.1016/j.neulet.2016.07.038
|
[3] |
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5):405-424.
doi: 10.1038/gim.2015.30
pmid: 25741868
|
[4] |
Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009[J]. Epilepsia, 2010, 51(4):676-685.
doi: 10.1111/epi.2010.51.issue-4
|
[5] |
Mercimek-Mahmutoglu S, Patel J, Cordeiro D, et al. Diagnostic yield of genetic testing in epileptic encephalopathy in childhood[J]. Epilepsia, 2015, 56(5):707-716.
doi: 10.1111/epi.12954
pmid: 25818041
|
[6] |
McTague A, Howell KB, Cross JH, et al. The genetic landscape of the epileptic encephalopathies of infancy and childhood[J]. Lancet Neurol, 2016, 15(3):304-316.
doi: 10.1016/S1474-4422(15)00250-1
pmid: 26597089
|
[7] |
Hu C, Chen W, Myers SJ, et al. Human GRIN2B variants in neurodevelopmental disorders[J]. J Pharmacol Sci, 2016, 132(2):115-121.
doi: 10.1016/j.jphs.2016.10.002
|
[8] |
Platzer K, Yuan H, Schütz H, et al. GRIN2B ence-phalopathy: novel findings on phenotype, variant clustering, functional consequences and treatment aspects[J]. J Med Genet, 2017, 54(7):460-470.
doi: 10.1136/jmedgenet-2016-104509
pmid: 28377535
|
[9] |
Schidlitzki A, Twele F, Klee R, et al. A combination of NMDA and AMPA receptor antagonists retards granule cell dispersion and epileptogenesis in a model of acquired epilepsy[J]. Sci Rep, 2017, 7(1):12191-12210.
doi: 10.1038/s41598-017-12368-6
pmid: 28939854
|
[10] |
Addis L, Virdee JK, Vidler LR, et al. Epilepsy-associated GRIN2A mutations reduce NMDA receptor trafficking and agonist potency - molecular profiling and functional rescue[J]. Sci Rep, 2017, 7(1):66.
doi: 10.1038/s41598-017-00115-w
pmid: 28242877
|
[11] |
Li J, Zhang J, Tang W, et al. De novo GRIN variants in NMDA receptor M2 channel pore-forming loop are associated with neurological diseases[J]. Hum Mutat, 2019, 40(12):2393-2413.
doi: 10.1002/humu.v40.12
|
[12] |
Platzer K, Lemke JR. GRIN2B-Related Neuro-developmental Disorder[M]// Adam MP, Ardinger HH, Pagon RA, et al. GeneReviews®[Internet]. Seattle (WA): University of Washington, Seattle, 1993-2021.
|
[13] |
Lemke JR, Hendrickx R, Geider K, et al. GRIN2B mutations in West syndrome and intellectual disability with focal epilepsy[J]. Ann Neurol, 2014, 75(1):147-154.
doi: 10.1002/ana.24073
|
[14] |
Mullier B, Wolff C, Sands ZA, et al. GRIN2B gain of function mutations are sensitive to radiprodil, a negative allosteric modulator of GluN2B-containing NMDA receptors[J]. Neuropharmacology, 2017, 123:322-331.
doi: S0028-3908(17)30229-0
pmid: 28533163
|